| 000 | 01692 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515052120.0 | ||
| 264 | 0 | _c20070418 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a1096-7192 | ||
| 024 | 7 |
_a10.1016/j.ymgme.2006.09.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuenzer, Joseph | |
| 245 | 0 | 0 |
_aA phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). _h[electronic resource] |
| 260 |
_bMolecular genetics and metabolism _cMar 2007 |
||
| 300 |
_a329-37 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aGlycosaminoglycans _xurine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIduronate Sulfatase _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunoglobulin G _xbiosynthesis |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aJoints _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMucopolysaccharidosis II _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aSpleen _xdrug effects |
| 700 | 1 | _aGucsavas-Calikoglu, Muge | |
| 700 | 1 | _aMcCandless, Shawn E | |
| 700 | 1 | _aSchuetz, Thomas J | |
| 700 | 1 | _aKimura, Alan | |
| 773 | 0 |
_tMolecular genetics and metabolism _gvol. 90 _gno. 3 _gp. 329-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ymgme.2006.09.001 _zAvailable from publisher's website |
| 999 |
_c16752499 _d16752499 |
||